HOME >> BIOLOGY >> NEWS
Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer

Some patients with advanced nonsmall-cell lung cancer (NSCLC) have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.

Recent randomized studies have shown that the addition of platinum-based drugs to standard chemotherapy improves patient outcomes. Based on this data, new guidelines for treating advanced NSCLC recommend platinum-based chemotherapy as the standard of care. Most clinicians in North America prefer carboplatin to cisplatin because it has fewer side effects and is easier to administer. Nonetheless, it was unclear whether the drugs are equally effective in NSCLC patients.

Andrea Ardizzoni, M.D., of University Hospital in Parma, Italy, and colleagues conducted a review of nine randomized trials comparing the survival of 2,968 NSCLC patients who received either cisplatin- or carboplatin-based chemotherapy.

Patients who received cisplatin lived slightly longer than those treated with carboplatin, with a median survival of 9.1 months compared with 8.4 months. The difference in survival was not statistically significant, except in patients treated with more recent chemotherapy combinations and those with nonsquamous-cell tumors. Both drugs had side effects. Carboplatin was more likely to decrease blood platelet levels, while cisplatin was more likely to cause nausea, vomiting, and damage to the kidneys.

Given the palliative nature of chemotherapy treatment in advanced NSCLC and the unquestionable practical advantage of carboplatin in terms of ease of administration, it could be argued that the small benefit achieved with cisplatin relative to carboplatin does not justify its preferential use in clinical practice. However, all the progress in the treatment
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
5-Jun-2007


Page: 1 2

Related biology news :

1. Smokeless tobacco more effective than cigarettes for delivering dangerous carcinogens into the body
2. Developing a more effective vaccine for tuberculosis
3. Cost-effective method for gene silencing is featured in Cold Spring Harbor Protocols
4. Implanon, Norplant and Jadelle are all effective contraceptives -- but side effects vary
5. High blood pressure medication strategy proves effective in Hispanic women
6. New compound effectively treats fungal infections
7. Northern forests less effective than tropical forests in reducing global warming
8. Scientists develop new drugs to fight colon and breast cancer more effectively
9. Avian influenza survivors antibodies effective at neutralising H5N1 strain
10. Studies assess effectiveness of serotonin and nerve stimulants on irritable bowel syndromes
11. Engineered protein effective against Staphylococcus aureus toxin

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 20, 2020 , ... NDA ... , a Clinical Operations executive with expertise in clinical trial planning and feasibility, ... as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design and ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently ... ideal for public health agencies of all sizes. With a focus on tracking ... individuals find appropriate health care, Mosio helps public health departments automate communications and ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine middle school teachers ... Scholar Program, a unique professional development program that provides advanced STEM (science, technology, ... science teachers nationwide. , Created in partnership between the National Stem Cell Foundation ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, a ... laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management ...
(Date:7/7/2020)... ... 2020 , ... R3 International is now offering stem cell therapy for Alzheimers ... Depending on the patient's condition, treatment may be offered IV, intrathecal or with a ... of Alzheimers dementia, and the incidence continues to increase as individuals live longer. There ...
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Security Industry ... its strong opposition to the recently introduced bicameral Facial Recognition and Biometric ... most federal use of nearly all biometric and related image analytics technologies, incorrectly ...
Breaking Biology Technology:
Cached News: